BG36199A3 - Method for preparing derivatives of 3- (1- piperidinylalkyl)- 4h- pyrido (1, 2- a) pyrimidin- 4- on - Google Patents
Method for preparing derivatives of 3- (1- piperidinylalkyl)- 4h- pyrido (1, 2- a) pyrimidin- 4- onInfo
- Publication number
- BG36199A3 BG36199A3 BG051433A BG5143381A BG36199A3 BG 36199 A3 BG36199 A3 BG 36199A3 BG 051433 A BG051433 A BG 051433A BG 5143381 A BG5143381 A BG 5143381A BG 36199 A3 BG36199 A3 BG 36199A3
- Authority
- BG
- Bulgaria
- Prior art keywords
- piperidinylalkyl
- pyrido
- pyrimidin
- preparing derivatives
- preparing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13484580A | 1980-03-28 | 1980-03-28 | |
| US06/191,632 US4342870A (en) | 1980-03-28 | 1980-09-29 | Novel 3-(1-piperidinylalkyl)-4H-pyrido[1,2-a]pyrimidin-4-one derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BG36199A3 true BG36199A3 (en) | 1984-09-14 |
Family
ID=26832744
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BG051433A BG36199A3 (en) | 1980-03-28 | 1981-03-27 | Method for preparing derivatives of 3- (1- piperidinylalkyl)- 4h- pyrido (1, 2- a) pyrimidin- 4- on |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US4342870A (enEXAMPLES) |
| EP (1) | EP0037265B1 (enEXAMPLES) |
| AU (1) | AU537700B2 (enEXAMPLES) |
| BG (1) | BG36199A3 (enEXAMPLES) |
| CA (1) | CA1163994A (enEXAMPLES) |
| CS (1) | CS256366B2 (enEXAMPLES) |
| DE (1) | DE3168433D1 (enEXAMPLES) |
| DK (1) | DK159390C (enEXAMPLES) |
| ES (1) | ES500814A0 (enEXAMPLES) |
| FI (1) | FI71737C (enEXAMPLES) |
| GR (1) | GR72488B (enEXAMPLES) |
| HU (1) | HU187329B (enEXAMPLES) |
| IE (1) | IE51319B1 (enEXAMPLES) |
| IL (1) | IL62494A (enEXAMPLES) |
| MA (1) | MA19107A1 (enEXAMPLES) |
| NO (1) | NO156752C (enEXAMPLES) |
| NZ (1) | NZ196522A (enEXAMPLES) |
| PH (1) | PH16530A (enEXAMPLES) |
| PT (1) | PT72740B (enEXAMPLES) |
| RO (1) | RO82508A (enEXAMPLES) |
| SU (1) | SU1068037A3 (enEXAMPLES) |
| YU (1) | YU43010B (enEXAMPLES) |
Families Citing this family (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4443451A (en) * | 1981-07-15 | 1984-04-17 | Janssen Pharmaceutica N.V. | Bicyclic pyrimidin-5-one derivatives |
| US4548938A (en) * | 1981-07-15 | 1985-10-22 | Janssen Pharmaceutica N.V. | 5-H-1,3,4-thiadiazolo[3,2-a]pyrimidin-5-one compounds |
| US4355037A (en) * | 1981-11-12 | 1982-10-19 | Hoechst-Roussel Pharmaceuticals | 3-(4-Piperidyl)-1,2-benzisoxales |
| US4485107A (en) * | 1982-11-01 | 1984-11-27 | Janssen Pharmaceutica N.V. | [[Bis(aryl)methylene]-1-piperidinyl]alkyl-pyrimidinones |
| US4581171A (en) * | 1983-07-27 | 1986-04-08 | Janssen Pharmaceutica, N.V. | [[Bis(aryl)methylene]-1-piperidinyl]alkyl-pyrimidinones useful for treating psychotropic disorders |
| US4888426A (en) * | 1983-11-30 | 1989-12-19 | Janssen Pharmaceutica N.V. | 1-(5-methyl-furan-2-ylmethyl)-N-(4-piperidinyl)imidazo [4,5-6]pyridine-2-amine |
| US4695569A (en) * | 1983-11-30 | 1987-09-22 | Janssen Pharmaceutica N.V. | Bicyclic heterocyclyl containing N-(bicyclic heterocyclyl)-4-piperidinamines |
| PH23995A (en) * | 1984-01-09 | 1990-02-09 | Janssen Pharmaceutica Nv | 4((bicycle heterocyclyl)-methyl and hetero)piperidines |
| US4548939A (en) * | 1984-10-01 | 1985-10-22 | Janssen Pharmaceutica N. V. | 1H-Indol-3-yl containing 1,3-dimethyl-1H-purine-2,6-diones |
| US4804663A (en) * | 1985-03-27 | 1989-02-14 | Janssen Pharmaceutica N.V. | 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles |
| ES2094718T3 (es) * | 1986-09-22 | 1997-02-01 | Janssen Pharmaceutica Nv | Antagonistas de la serotonine para el tratamiento de heridas. |
| IL90879A0 (en) * | 1988-09-02 | 1990-02-09 | Janssen Pharmaceutica Nv | 3-piperidinyl-indazole derivatives,their preparation and antihypertensive compositions containing them |
| CA2000786C (en) * | 1988-11-07 | 1999-01-26 | Cornelus G. M. Janssen | 3-piperidinyl-1,2-benzisoxazoles |
| US5153206A (en) * | 1988-12-02 | 1992-10-06 | Pfizer Inc. | Arylpiperidine derivatives |
| JPH04504263A (ja) * | 1989-03-23 | 1992-07-30 | マリンクロッド・インコーポレイテッド | 放射性沃素又は臭素標識ピペリジン化合物、並びに上記化合物の及び上記化合物を含む組成物の製法 |
| DE4138756A1 (de) * | 1991-11-26 | 1993-05-27 | Troponwerke Gmbh & Co Kg | Kombination mit neuroprotektiver wirkung |
| US5266571A (en) * | 1992-01-09 | 1993-11-30 | Amer Moh Samir | Treatment of hemorrhoids with 5-HT2 antagonists |
| AU669156B2 (en) * | 1992-02-13 | 1996-05-30 | Merrell Dow Pharmaceuticals Inc. | Piperidinyl thiacyclic derivatives |
| ES2159526T3 (es) * | 1992-07-13 | 2001-10-16 | Janssen Pharmaceutica Nv | Nuevos derivados de 4-(3-benzofuranil)piperidinilo y 4-(3-benzotienil)piperidinilo y composiciones farmaceuticas que los contienen. |
| JP3645906B2 (ja) * | 1993-11-19 | 2005-05-11 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | マイクロカプセル封入された３−ピペリジニル−置換１，２−ベンズイソオキサゾール類及び１，２−ベンズイソチアゾール類 |
| ES2085234B1 (es) * | 1994-02-24 | 1997-01-16 | Vita Invest Sa | Agente activo sobre el sistema nervioso central, procedimiento para su preparacion y composiciones farmaceuticas que lo contienen. |
| TW421649B (en) * | 1995-01-31 | 2001-02-11 | Janssen Pharmaceutica Nv | 4-(1H-indol-1yl)-1-piperidinyl derivatives |
| US5753664A (en) * | 1995-03-16 | 1998-05-19 | Takeda Chemical Industries, Ltd. | Heterocyclic compounds, their production and use |
| HRP20050424A2 (en) * | 2002-11-13 | 2006-08-31 | Synthon B.V. | Process for making risperidone and intermediates thereof |
| EP1615923A1 (en) * | 2003-04-22 | 2006-01-18 | Synthon B.V. | Risperidone monohydrochloride |
| EP3106166B1 (en) * | 2008-02-29 | 2020-12-02 | VM Therapeutics LLC | Compounds for treating pain syndrome and other disorders |
| CN119528903A (zh) | 2012-02-10 | 2025-02-28 | Ptc医疗公司 | 用于治疗脊髓性肌萎缩的化合物 |
| EA029155B1 (ru) | 2012-03-01 | 2018-02-28 | ПиТиСи ТЕРАПЬЮТИКС, ИНК. | Соединения для лечения спинальной мышечной атрофии |
| MX358514B (es) | 2012-03-23 | 2018-08-24 | Ptc Therapeutics Inc | Compuestos para tratar la atrofia muscular espinal. |
| US9724348B2 (en) | 2013-03-15 | 2017-08-08 | Vm Therapeutics Llc | Crystalline forms |
| WO2015105657A1 (en) | 2013-12-19 | 2015-07-16 | Ptc Therapeutics, Inc. | Methods for modulating the amount of rna transcripts |
| EP3310169B1 (en) | 2015-05-30 | 2023-05-17 | PTC Therapeutics, Inc. | Methods for modulating rna splicing |
| PT3386511T (pt) | 2015-12-10 | 2021-07-14 | Ptc Therapeutics Inc | Métodos para tratamento da doença de huntington |
| JP2019535789A (ja) | 2016-11-28 | 2019-12-12 | ピーティーシー セラピューティクス，インコーポレーテッド | Ｒｎａスプライシングを調節する方法 |
| EP4151627A1 (en) | 2017-06-05 | 2023-03-22 | PTC Therapeutics, Inc. | Compounds for treating huntington's disease |
| BR112019026508A2 (pt) | 2017-06-14 | 2020-07-14 | Ptc Therapeutics, Inc. | métodos para modificar o splicing do rna |
| WO2019005993A1 (en) | 2017-06-28 | 2019-01-03 | Ptc Therapeutics, Inc. | METHODS OF TREATING HUNTINGTON'S DISEASE |
| BR112019027717A2 (pt) | 2017-06-28 | 2020-07-28 | Ptc Therapeutics, Inc. | métodos para tratar a doença de huntington |
| EA202092001A1 (ru) | 2018-03-27 | 2021-01-29 | ПиТиСи ТЕРАПЬЮТИКС, ИНК. | Соединения для лечения болезни гентингтона |
| SMT202400286T1 (it) | 2018-06-27 | 2024-09-16 | Ptc Therapeutics Inc | Composti eterociclici ed eteroarilici per il trattamento della corea di huntington |
| JP7515415B2 (ja) | 2018-06-27 | 2024-07-12 | ピーティーシー セラピューティクス， インコーポレイテッド | ハンチントン病を処置するためのヘテロアリール化合物 |
| US11685746B2 (en) | 2018-06-27 | 2023-06-27 | Ptc Therapeutics, Inc. | Heteroaryl compounds for treating Huntington's disease |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3412094A (en) * | 1967-06-21 | 1968-11-19 | Searle & Co | 5-alkyl-2-amino-4-azido-6-phenylpyrimidines and congeners |
| US3960863A (en) * | 1974-06-25 | 1976-06-01 | Sankyo Company Limited | Pyrido[1,2-a]pyrimidinone derivatives |
| JPS5146497A (en) * | 1974-10-19 | 1976-04-20 | Masato Aiura | Hobuban |
| JPS525795A (en) * | 1975-06-28 | 1977-01-17 | Sankyo Co Ltd | Preparation of tetrahydro pyridopyrimidinone derivatives |
| HU173438B (hu) * | 1975-11-27 | 1979-05-28 | Chinoin Gyogyszer Es Vegyeszet | Sposob poluchenija novykh proizvodnykh 4-okso-1,6,7,8-/tetragidro-4h-pirido/1,2/pirimidina s zaderzhivajuhhejj vozgoranie aktivnot'ju i protivosvertivajuhhem effektom |
-
1980
- 1980-09-29 US US06/191,632 patent/US4342870A/en not_active Expired - Lifetime
-
1981
- 1981-03-03 GR GR64291A patent/GR72488B/el unknown
- 1981-03-04 CA CA000372258A patent/CA1163994A/en not_active Expired
- 1981-03-17 NZ NZ196522A patent/NZ196522A/en unknown
- 1981-03-17 AU AU68429/81A patent/AU537700B2/en not_active Ceased
- 1981-03-21 MA MA19313A patent/MA19107A1/fr unknown
- 1981-03-24 CS CS812134A patent/CS256366B2/cs unknown
- 1981-03-24 SU SU813261927A patent/SU1068037A3/ru active
- 1981-03-26 DK DK138281A patent/DK159390C/da not_active IP Right Cessation
- 1981-03-26 PH PH25429A patent/PH16530A/en unknown
- 1981-03-26 IL IL62494A patent/IL62494A/xx unknown
- 1981-03-26 PT PT72740A patent/PT72740B/pt not_active IP Right Cessation
- 1981-03-27 ES ES500814A patent/ES500814A0/es active Granted
- 1981-03-27 IE IE706/81A patent/IE51319B1/en not_active IP Right Cessation
- 1981-03-27 EP EP81301335A patent/EP0037265B1/en not_active Expired
- 1981-03-27 HU HU81783A patent/HU187329B/hu not_active IP Right Cessation
- 1981-03-27 NO NO811058A patent/NO156752C/no unknown
- 1981-03-27 YU YU810/81A patent/YU43010B/xx unknown
- 1981-03-27 DE DE8181301335T patent/DE3168433D1/de not_active Expired
- 1981-03-27 FI FI810956A patent/FI71737C/fi not_active IP Right Cessation
- 1981-03-27 BG BG051433A patent/BG36199A3/xx unknown
- 1981-03-28 RO RO81103848A patent/RO82508A/ro unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RO82508B (ro) | 1983-08-30 |
| DK159390C (da) | 1991-03-04 |
| GR72488B (enEXAMPLES) | 1983-11-14 |
| YU43010B (en) | 1989-02-28 |
| SU1068037A3 (ru) | 1984-01-15 |
| RO82508A (ro) | 1983-09-26 |
| IE810706L (en) | 1981-09-28 |
| US4342870A (en) | 1982-08-03 |
| EP0037265B1 (en) | 1985-01-23 |
| NO156752B (no) | 1987-08-10 |
| CS256366B2 (en) | 1988-04-15 |
| DK159390B (da) | 1990-10-08 |
| HU187329B (en) | 1985-12-28 |
| PT72740A (en) | 1981-04-01 |
| DE3168433D1 (de) | 1985-03-07 |
| MA19107A1 (fr) | 1981-10-01 |
| NO811058L (no) | 1981-09-29 |
| DK138281A (da) | 1981-09-29 |
| PH16530A (en) | 1983-11-10 |
| FI71737B (fi) | 1986-10-31 |
| NZ196522A (en) | 1985-10-11 |
| FI810956L (fi) | 1981-09-29 |
| FI71737C (fi) | 1987-02-09 |
| IE51319B1 (en) | 1986-12-10 |
| ES8300763A1 (es) | 1982-11-01 |
| NO156752C (no) | 1987-11-18 |
| IL62494A (en) | 1984-08-31 |
| CA1163994A (en) | 1984-03-20 |
| PT72740B (en) | 1982-11-16 |
| IL62494A0 (en) | 1981-05-20 |
| YU81081A (en) | 1983-12-31 |
| AU6842981A (en) | 1981-10-01 |
| ES500814A0 (es) | 1982-11-01 |
| AU537700B2 (en) | 1984-07-05 |
| EP0037265A1 (en) | 1981-10-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BG36199A3 (en) | Method for preparing derivatives of 3- (1- piperidinylalkyl)- 4h- pyrido (1, 2- a) pyrimidin- 4- on | |
| BG40654A3 (bg) | Метод за получаване на циклоалкилтриазоли | |
| BG40655A3 (en) | Method for preparing n- (bi heterocyclic)- 4- piperidineamines | |
| BG31496A3 (bg) | Метод за получаване на 4-амино-5-алкил-сулфонил ортоанизамиди | |
| BG37995A3 (en) | Method for preparing derivatives of 2- cyanbenzimidazol | |
| BG35327A3 (bg) | Метод за получаване на пиридоксинови производни | |
| BG29287A3 (bg) | Метод за получаване на субституирани 6-фенил-1,2,4-триазоло(4,3-в)- пиридазини | |
| BG32851A3 (bg) | Метод за получаване на 3,4,5,6-тетрахидро-2н- -1-бензоксецини | |
| BG35328A3 (en) | Method for preparing imidodisulphamidic derivatives | |
| BG38334A3 (en) | Method for preparing pyrolidinic derivatives | |
| BG29722A3 (bg) | Метод за получаване на 2,5-дисубституирани пиримидин-4-они | |
| BG28712A3 (bg) | Метод за получаване на заместени в 11-а позиция,5,11-дихидро-6н-пиридо (2,3-в)(1,4)бензодиазепин-6-они | |
| BG28709A3 (bg) | Метод за получаване на 3-(1-пиразолил)-пиридазинови производни | |
| BG36348A3 (en) | Method for preparing thienopyridinon derivatives | |
| BG34907A3 (en) | Method for preparing benzodiazepine compounds | |
| BG38489A3 (en) | Method for preparing oxazophosphorine- 6, 4- thiolcalsulphonic acids and their neutral salts | |
| BG28711A3 (bg) | Метод за получаване на заместени в 11-а позиция 5,11-дихидро-6н-пиридо (2,3-в)(1,4)бензодиазепин-6-они | |
| BG35039A3 (bg) | Метод за получаване на заместени хетероциклични феноксиамини | |
| BG28714A4 (bg) | Метод за получаване на 5,11-дихидро-6н-пиридо(2,3-в)(1,4) бензодиазепин-6-они | |
| BG40803A3 (bg) | Метод за получаване на арилциклобутилалкиламинови производни | |
| BG35464A3 (en) | Method preparing fluorene derivatives | |
| BG38638A3 (bg) | Метод за получаване на арилциклобутил-аминопроизводни | |
| BG36935A3 (en) | Method for preparing benzodiazepine compounds | |
| BG40315A3 (bg) | Метод за получаване на ауронови производни | |
| BG35897A3 (bg) | Метод за получаване на 5-(дихидрокси-фенокси)-1н-тетразоли |